Search

everythinglearnresearchcommunity

for

Search:↓

Zouboulis syndrome is a rare condition that helps diagnose monosomy 18p early.

Jujube fruit extract may reduce kidney damage from ibuprofen in rats.

Hair can indicate early signs of metabolic disorders, with issues like protein deficiency stopping hair growth.

PFS might be a delusional disorder with potential to become mass psychogenic illness.

Gene therapy shows promise for enhancing physical traits but faces ethical, safety, and regulatory challenges.

Hair characteristics might be early signs of Type 2 Diabetes and could help with early prevention.

A baby boy with 13q deletion syndrome had eye cancer, a woman's vision improved after stopping a breast cancer drug, a man developed cataracts from using Propecia, and a rare skin disorder called Lipoid Proteinosis was discussed. Also, a tool called OCT is useful for diagnosing macular diseases.

Allopregnanolone is needed for certain brain processing issues caused by D1 dopamine receptor activation.

Antidepressants can cause long-term side effects like severe withdrawal symptoms and sexual dysfunction, which can last for months or years after stopping the medication.

Combining mood stabilizers with antipsychotics is more effective for treating children with bipolar disorder than using mood stabilizers alone.

Taking Propecia might lead to the development of cataracts.

Understanding and manipulating epigenetic changes can potentially lead to human organ regeneration therapies, but more research is needed to improve these methods and minimize risks.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Mitochondrial therapy and platelet-rich plasma therapy both stimulated hair regrowth in aging mice, with mitochondrial therapy showing similar effectiveness to plasma therapy.

The document discusses various eye conditions and their treatments, including a rare eye cancer in a baby, vision loss from a cancer drug, cataracts from a baldness treatment, a rare skin disorder, and a specific type of eye disease diagnosed with a special imaging technique.

Hair loss lowers quality of life, causing embarrassment, frustration, and sexual rejection.

Finasteride can cause lasting sexual dysfunction, depression, and other side effects, needing more research for treatment.

Melatonin increases cashmere quality in goats but reduces their milk production and doesn't affect their offspring's hair growth.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Researchers found a new ABCD1 gene mutation linked to a rare brain and nerve disorder with unusual brain changes.

Most hospitalized internal medicine patients have undiagnosed skin problems and want them treated.

Finasteride, often used for hair loss, can potentially cause cataracts.

The article suggests that the view of male baldness as a medical issue is influenced by commercial bias and calls for more unbiased research.

Improved finasteride formula allows slow, sustained release and better absorption for patients.

Escitalopram might effectively treat delusions of parasitosis and possibly Morgellons disease, with psychological factors being important to consider.

Phthirusa pyrifolia extract may lower testosterone and harm male rat reproduction without damaging the liver or kidneys.

The document concludes that early diagnosis and a comprehensive treatment plan are crucial for managing hair loss in children, with a focus on both medical and psychological support.

Multiple eye conditions were studied, highlighting the importance of various imaging methods for diagnosis, the vision side effects of drugs tamoxifen and Propecia, and the usefulness of optical coherence tomography for diagnosing and monitoring macular and retinal diseases.

The conclusion is that certain genetic factors and blood types may affect COVID-19 severity, but changes in ACE2 and TMPRSS2 genes are not clearly linked to it.